Monte Rosa Therapeutics, Inc. (GLUE)

NASDAQ: GLUE · IEX Real-Time Price · USD
10.03
+0.87 (9.50%)
Aug 12, 2022 4:00 PM EDT - Market closed

Cash Flow Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 202120202019
Net Income
-73.96-35.88-7.74
Depreciation & Amortization
2.130.540.07
Share-Based Compensation
5.20.350
Other Operating Activities
7.2611.941.5
Operating Cash Flow
-59.36-23.05-6.17
Capital Expenditures
-9.65-3.39-1.39
Investing Cash Flow
-9.65-3.39-1.39
Share Issuance / Repurchase
237.900
Debt Issued / Paid
000.75
Other Financing Activities
139.6660.0614.25
Financing Cash Flow
377.5660.0615
Net Cash Flow
308.5533.627.44
Free Cash Flow
-69.02-26.44-7.56
Free Cash Flow Per Share
-2.76-17.43-1.51
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).